MedTrace Logo

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

NCT02689258 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 277

Last updated 2026-03-02

Study results available
· View outcomes & findings →

Summary

A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery

Conditions

  • Postoperative Pain

Interventions

DRUG

Bupivicaine HCl

Bupivacaine HCl via injection

DRUG

HTX-011B

HTX- 011B (bupivacaine/meloxicam) via injection

DRUG

Placebo

Saline placebo via injection

DRUG

HTX-011A

HTX- 011A (bupivacaine/meloxicam) via injection

DRUG

HTX-002

HTX-002 via combination

Sponsors & Collaborators

  • Heron Therapeutics

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-23
Primary Completion
2017-03-31
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689258 on ClinicalTrials.gov